CLOSE
Loading...
Research Infrastructure Registry in Cyprus

CSHM

GENERAL INFORMATION

Description and purpose of the Research Infrastructure

The Centre for the Study of Haematological and other Malignancies (CSHM) is a research institution that was established with government support and funding from the Research Promotion Foundation as a Strategic Research Infrastructure. Through the Center’s activities, the Karaiskakio Foundation managed to establish one of the most advanced integrated diagnostic centers in Europe. CSHM is continuing its research in target discovery for treating diseases such as cancer and establishes technologies for research, available to the local and international scientific community.

USEFUL FIGURES

Personnel

13

Personnel

Male

23%

Male

Female

77%

Female

Publications

45

Publications

ACCESS TO INFRASTRUCTURE

  • Academia
  • Industry

CONTACT INFO

INFORMATION OF INSTRUMENTATION OPERATING IN THE INFRASTRUCTURE

Cell Sorter - BD FACSAria III
  • Name:  Cell Sorter - BD FACSAria III
  • Description:  The BD FACSAria™ III Cell Sorter is a high-performance flow cytometry system which supports up to four-way sorting.
  • Units:  1
  • Hosting Laboratory / Department:  Center for the Study of Haematological and other Malignancies
Brief description of the utilization of the instrument:
The BD FACSAria™ III Cell Sorter is a high-performance flow cytometry system developed by BD Biosciences, designed to deliver precise, high-speed sorting of specific cell populations for research and clinical applications. It supports up to four-way sorting with exceptional purity, recovery, and throughput, analyzing tens of thousands of events per second.
Year:  2018
Funding Source: 
  • Own

Available for access
by external users

Flow Cytometer - Cytek AURORA
  • Name:  Flow Cytometer - Cytek AURORA
  • Description:  The Cytek Aurora leverages full spectrum technology to provide unprecedented flexibility to scientists, enabling the use of a wide array of new fluorochrome combinations without reconfiguring the system for each application.
  • Units:  1
  • Hosting Laboratory / Department:  Center for the Study of Haematological and other Malignancies
Brief description of the utilization of the instrument:
The Aurora system delivers high-resolution data at the single-cell level to resolve the most challenging cell populations, such as cells with high autofluorescence or low levels of expression of key biomarkers, regardless of assay complexity. The Full Spectrum Profiling technology employed by the Aurora can improve data clarity and resolution with autofluorescence extraction.
Year:  2020
Funding Source: 
  • National

Available for access
by external users

Next Generation Sequencer - NextSeq 2000 Ilumina
  • Name:  Next Generation Sequencer - NextSeq 2000 Ilumina
  • Description:  The NextSeq 2000 Illumina is a Next Generation Sequencing (NGS) platform designed for high-throughput, flexible, and scalable sequencing.
  • Units:  2
  • Hosting Laboratory / Department:  Center for the Study of Haematological and other Malignancies
Brief description of the utilization of the instrument:
The NextSeq 2000 supports a wide range of applications such as whole-genome sequencing, transcriptome analysis, targeted panels, and single-cell RNA sequencing. With its innovative patterned flow cells, XLEAP-SBS chemistry, and integrated DRAGEN bioinformatics, the NextSeq 2000 offers fast, accurate, and cost-effective sequencing suitable for both research and clinical laboratories.
Year:  2021
Funding Source: 
  • National

Available for access
by external users

Multiplex Flow Analyzer - LABScan3D™
  • Name:  Multiplex Flow Analyzer - LABScan3D™
  • Description:  The LABScan3D™ is a multiplex flow analyzer, which processes LABType™ assays for HLA typing of Class I/II alleles, and LABScreen™ assays for HLA antibody screening, detection of DSA, and profiling complement binding antibodies.
  • Units:  1
  • Hosting Laboratory / Department:  Center for the Study of Haematological and other Malignancies
Brief description of the utilization of the instrument:
The LABScan3D™ is an advanced multiplex flow cytometry platform developed by One Lambda (Thermo Fisher Scientific), specifically designed for histocompatibility and immunogenetics laboratories. It combines 3D optical detection technology with Luminex® xMAP® technology, enabling simultaneous detection of multiple analytes in a single sample.
Year:  2023
Funding Source: 
  • Private

Available for access
by external users

Single Cell Genomics Platform - 10x Genomics
  • Name:  Single Cell Genomics Platform - 10x Genomics
  • Description:  The 10x Genomics Single Cell Genomics Platform enables high-throughput profiling of individual cells, providing deep insights into cellular heterogeneity.
  • Units:  1
  • Hosting Laboratory / Department:  Center for the Study of Haematological and other Malignancies
Brief description of the utilization of the instrument:
The 10x Genomics Single Cell Genomics Platform enables high-throughput profiling of individual cells, providing deep insights into cellular heterogeneity. Using microfluidics and barcoding technology, it allows the analysis of gene expression, chromatin accessibility, or immune repertoires at single-cell resolution across thousands to millions of cells in a single run.
Year:  2024
Funding Source: 
  • Private

Available for access
by external users